Long term treatment of rheumatoid arthritis with high doses of intravenous immunoglobulins: effects on disease activity and serum cytokines (Q33567294)

28 July 2017

Long term treatment of rheumatoid arthritis with high doses of intravenous immunoglobulins: effects on disease activity and serum cytokines (English)

1 reference

28 July 2017

1 reference

9

Gerli R

1 reference

28 July 2017

Muscat C

1

1 reference

28 July 2017

Bertotto A

2

1 reference

28 July 2017

Ercolani R

3

1 reference

28 July 2017

Bistoni O

4

1 reference

28 July 2017

Agea E

5

1 reference

28 July 2017

Cesarotti M

6

1 reference

28 July 2017

Fiorucci G

7

1 reference

28 July 2017

Spinozzi F

8

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 May 1995

1 reference

Annals of the Rheumatic Diseases

28 July 2017

1 reference

28 July 2017

54

1 reference

28 July 2017

382-385

1 reference

28 July 2017

5

1 reference

Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1005599

How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis?

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1005599

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1005599

Human placenta-eluted gammaglobulins in immunomodulating treatment of rheumatoid arthritis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1005599

Rheumatoid arthritis. Pathophysiology and implications for therapy

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1005599

Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1005599

Manipulating the Immune System with Immune Globulin

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1005599

Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1005599

Immunologically active proteins in intravenous immunoglobulin

14 July 2018

1 reference

12 December 2020

High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease

1 reference

12 December 2020

Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy

1 reference

12 December 2020

Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group

1 reference

12 December 2020

Intravenous gamma globulin therapy in systemic juvenile rheumatoid arthritis

1 reference

12 December 2020

High-dose immunoglobulin therapy as an immunomodulatory treatment of rheumatoid arthritis

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.54.5.382

1 reference

28 July 2017

1 reference

28 July 2017

1 reference